A potentially lethal bacterium protects itself by causing immune tunnel vision, according to a study from scientists at the University of Chicago published in the Journal of Experimental Medicine. By tricking the immune system into focusing on one bug-associated factor, the bacterium Staphylococcus aureus dodges the production of antibodies that would otherwise protect against infection.
Staphylococcus aureus accounts for roughly 20 percent of hospital-acquired blood infections, and antibiotic-resistant strains of the bug (MRSA) are on the rise. Unfortunately, efforts to protect people against Staph infections using vaccines have been largely unsuccessful. Studies in mice have shown that protection against Staph infection depends on the production of antibodies. Although several bacterial proteins can be recognized by human antibodies, these antibodies are often not enough to fight off infection or prevent re-infection.
Patrick Wilson and colleagues now find that although circulating antibodies in people infected with Staph aureus are capable of recognizing a broad range of bacterial proteins, the active immune response is focused on only one-protein A (SpA).
Antibody producing B cells express highly variable receptors on their surface, and normally only a few B cells are capable of recognizing a given molecule (“antigen”), often part of an invading pathogen. When a B cell encounters its specific antigen, it fine-tunes its surface receptor for better, faster recognition the second time around. But SpA acts as a “superantigen,” meaning that it binds to and activates many B cells regardless of their receptor specificity. Once activated, some of the B cells in Staph-infected people appeared to tune their receptors to recognize SpA rather than their intended antigens. This may allow the bug to overpower B cells that might otherwise generate protective antibodies specific for other bacterial components.
It’s not clear why antibodies against SpA are not protective, but these data suggest that future vaccine approaches must be designed to side-step this bacterial subterfuge.
Reference: Pauli NT, et al. 2014. J. Exp. Med. doi:10.1084/jem.20141404
Source: Rockefeller University Press
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.